915
Views
6
CrossRef citations to date
0
Altmetric
Brief Report

Increased virulence of neuraminidase inhibitor-resistant pandemic H1N1 virus in mice

Potential emergence of drug-resistant and virulent variants

, , , , , , , , , , , & show all
Pages 489-493 | Received 15 May 2013, Accepted 29 Jul 2013, Published online: 02 Aug 2013

Figures & data

Figure 1. Comparison and characterization of virulence between mouse-adapted and parental viruses in BALB/c mice. Five independent serial lung-to-lung passages for each virus (CA04 and CA04H274Y) were performed. After adaptation, 104.0 TCID50 of the passaged viruses and their parental strains were administered intranasally (i.n.). Body weight loss and survival rate of the parental CA04 and CA04H274Y with their corresponding mouse-adapted variants (maCA04_A, maCA04_B, maCA04_C, maCA04_D, and maCA04H274Y_A, maCA04H274Y_B, maCA04H274Y_C, and maCA04H274Y_D, respectively) were monitored in groups of 5 mice for 12 d p.i. (A–D). The number of passages is represented by ‘P’ followed by the name of the individually passaged viruses on the figure. For further characterization of lethal mouse-adapted oseltamivir-resistant variants, mouse-adapted viruses were plaque-purified and selected. Next, 103.0 TCID50 of plaque-purified mouse-adapted CA04, mouse-adapted CA04H274Y, and their parental viruses were administered to mice i.n. Body weight loss (E) and survival rate (F) were monitored daily for 12 d p.i. Groups of 12 mice were also given 103.0 TCID50, and lung samples were collected 1, 3, 5, and 7 d p.i. to determine lung viral titers (3 heads/day) (G). Standard hematoxylin and eosin staining of lung tissues infected by CA04 (H), CA04H274Y (I), mouse-adapted CA04 (J), and mouse-adapted CA04H274Y (K) was examined 5 d p.i. (magnification × 100). *P < 0.05 (unpaired t test, two-tailed) of viral lung titers between wild-type CA04 and CA04H274Y viruses and mouse-adapted CA04 and CA04H274Y viruses. Error bar shown in (C, E, and G) represents standard error mean (SEM).

Figure 1. Comparison and characterization of virulence between mouse-adapted and parental viruses in BALB/c mice. Five independent serial lung-to-lung passages for each virus (CA04 and CA04H274Y) were performed. After adaptation, 104.0 TCID50 of the passaged viruses and their parental strains were administered intranasally (i.n.). Body weight loss and survival rate of the parental CA04 and CA04H274Y with their corresponding mouse-adapted variants (maCA04_A, maCA04_B, maCA04_C, maCA04_D, and maCA04H274Y_A, maCA04H274Y_B, maCA04H274Y_C, and maCA04H274Y_D, respectively) were monitored in groups of 5 mice for 12 d p.i. (A–D). The number of passages is represented by ‘P’ followed by the name of the individually passaged viruses on the figure. For further characterization of lethal mouse-adapted oseltamivir-resistant variants, mouse-adapted viruses were plaque-purified and selected. Next, 103.0 TCID50 of plaque-purified mouse-adapted CA04, mouse-adapted CA04H274Y, and their parental viruses were administered to mice i.n. Body weight loss (E) and survival rate (F) were monitored daily for 12 d p.i. Groups of 12 mice were also given 103.0 TCID50, and lung samples were collected 1, 3, 5, and 7 d p.i. to determine lung viral titers (3 heads/day) (G). Standard hematoxylin and eosin staining of lung tissues infected by CA04 (H), CA04H274Y (I), mouse-adapted CA04 (J), and mouse-adapted CA04H274Y (K) was examined 5 d p.i. (magnification × 100). *P < 0.05 (unpaired t test, two-tailed) of viral lung titers between wild-type CA04 and CA04H274Y viruses and mouse-adapted CA04 and CA04H274Y viruses. Error bar shown in (C, E, and G) represents standard error mean (SEM).

Table 1. Amino acid substitutions identified after mouse adaptation of pandemic H1N1 2009 and oseltamivir-resistant variants

Table 2. Characteristics of growth efficiency and virulence, and neuraminidase-inhibitor susceptibility of wild-type and mouse-adapted pandemic H1N1 influenza viruses and their oseltamivir-resistant counterpart

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.